FDA drug record/Alzheimer's disease

FDA record

Alzheimer's disease

3 drugs, each read from FDA's own review documents and label.

DrugSponsorFirst approvedFDA documents
Kisunladonanemab-azbtEli Lilly Co.July 2, 202418
Leqembilecanemab-irmbEisai Inc.January 6, 202328
AduhelmaducanumabBiogenJune 7, 202124